SectorBiological Technology
Established Date10/03/2020
Listing Date02/07/2020
ExchangeNASDAQ Stock Exchange
Full-time Employees285
Fiscal Year Ends31/12
Security TypeCommon stock
Office addressPaul-Ehrlich-Strabe 15, 72076 Tubingen, Federal Republic of Germany
Business
IntroductionImmatics N.V., established on March 10, 2020, is a Dutch private limited liability company. The company is a biopharmaceutical company focused on the development of T-cell receptor-based immunotherapies.
